Unobserved versus observed office buprenorphine/naloxone induction: A pilot randomized clinical trial

Addictive Behaviors

Volumn 35, Issue 5, 2010, Pages 537-540

  Gunderson, Erik W ^a,b   Wang, Xin Qun ^c   Fiellin, David A ^d   Bryan, Benjamin ^b   Levin, Frances R ^b,e  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d YALE UNIVERSITY   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Buprenorphine; Buprenorphine naloxone; Induction; Opioid dependence treatment

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; COCAINE; DIAMORPHINE; ILLICIT DRUG; METHADONE; OPIATE;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; MAINTENANCE DRUG DOSE; MALE; PILOT STUDY; PRIMARY MEDICAL CARE; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; TELEPHONE; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; BUPRENORPHINE; DIRECTLY OBSERVED THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; NEW YORK; OPIOID-RELATED DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; PRIMARY HEALTH CARE; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77049127267     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2010.01.001     Document Type: Article

References (31)

1. Alford D.P., LaBelle C.T., Richardson J.M., O'Connell J.J., Hohl C.A., Cheng D.M., et al. Treating homeless opioid dependent patients with buprenorphine in an office-based setting. Journal of General Internal Medicine 22 (2007) 171-176 PMID: 17356982
2. Barry D.T., Irwin K.S., Jones E.S., Becker W.C., Tetrault J.M., Sullivan L.E., et al. Integrating buprenorphine treatment into office-based practice: A qualitative study. Journal of General Internal Medicine 24 (2009) 218-225 PMID: 19089500
3. Center for Substance Abuse Treatment (CSAT). Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939 (2004), Substance Abuse and Mental Health Services Administration, Rockville, MD
4. Center for Substance Abuse Treatment (CSAT) and National Institute on Drug Abuse (NIDA). Buprenorphine in the treatment of opioid addiction: Expanding access-enhancing quality. Summary of the Work Group Reports. Report of the 2008 Buprenorphine Summit III (2008, February 21-22), Substance Abuse and Mental Health Services Administration (SAMHSA), Washington, DC
5. Collins E.D., Horton T., Reinke K., Amass L., and Nunes E.V. Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation. Journal of Substance Abuse Treatment 32 (2007) 167-175 PMID 17306725
6. Drug and Alcohol Services Information System (DASIS). DASIS report: Facilities operating opioid treatment programs: 2005. Office of Applied Studies, Substance Abuse and Mental Health Services Administration, 2006 (2006) Available at: http://www.oas.samhsa.gov/2k6/OTP/OTP.htm. [Accessed December 19, 2009]
7. Fiellin D.A. The first three years of buprenorphine in the U.S: Experience to date and future directions. Journal of Addiction Medicine 1 (2007) 62-67
8. Fiellin D.A., Pantalon M.V., Chawarski M.C., Moore B.A., Sullivan L.E., O'Connor P.G., et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. New England Journal of Medicine 355 (2006) 365-374 PMID: 16870915
9. Gunderson E.W., and Fiellin D.A. Office-based maintenance treatment of opioid dependence: How does it compare with traditional approaches?. CNS Drugs 22 2 (2008) 99-111 PMID: 18193922
10. Gunderson E.W., Fiellin D.A., Levin F.R., Sullivan L.E., and Kleber H.D. Evaluation of a combined online and in person training on the use of buprenorphine. Substance Abuse 27 (2006) 39-45 PMID: 1713517
11. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology 32 (1959) 50-55 PMID: 13638508
12. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23 (1960) 56-62 PMID:14399272
13. Handelsman L., Cochrane K.J., Aronson M.J., Ness R.A., Rubinstein K.J., and Kanof P.D. Two new rating scales for opiate withdrawal. American Journal of Drug and Alcohol Abuse 13 (1987) 293-308 PMID: 3687892
14. Hser Y.I., Hoffman V., Grella C.E., and Anglin M.D. A 33-year follow-up of narcotics addicts. Archives of General Psychiatry 58 (2001) 503-508 PMID: 11343531
15. Kissin W., McLeod C., Sonnefeld J., and Stanton A. Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence. Journal of Addictive Diseases 25 (2006) 91-103 PMID: 17088229
16. Lee J.D., Grossman E., DiRocco D., and Gourevitch M.N. Home buprenorphine/naloxone induction in primary care. Journal of General Internal Medicine 24 (2009) 226-232 PMID: 19089508
17. Lintzeris N., Bammer G., Rushworth L., Jolley D.J., and Whelan G. Buprenorphine dosing regime for inpatient heroin withdrawal: A symptom-triggered dose titration study. Drug and Alcohol Dependence 70 (2003) 287-294 PMID: 12757966
18. Lloyd J. Drug policy information clearinghouse fact sheet: Heroin (2003), Office of National Drug Control Policy, Washington, DC
19. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., et al. The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment 9 3 (1992) 199-213 PMID: 1334156
20. Mintzer I.L., Eisenberg M., Terra M., MacVane C., Himmelstein D.U., and Woolhandler S. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings. Annals of Family Medicine 5 (2007) 146-150 PMID: 17389539
21. Netherland J., Botsko M., Egan J.E., Saxon A.J., Cunningham C.O., Findelstein R., et al. Factors affecting willingness to provide buprenorphine treatment. Journal of Substance Abuse Treatment 36 (2009) 244-251 PMID: 18715741
22. Sobell L.C., and Sobell M.B. Timeline Followback user's guide: A calendar method for assessing alcohol and drug use (1996), Addiction Research Foundation, Toronto, Canada
23. Soeffing J.M., Martin L.D., Fingerhood M.I., Jasinski D.R., and Rastegar D.A. Buprenorphine maintenance treatment in a primary care setting: Outcomes at 1 year. Journal of Substance Abuse Treatment 37 (2009) 426-430 PMID: 19553061
24. Sohler N.L., Li X., Kunins H.V., Sacajiu G., Giovanniello A., Whitley S., and Cunningham C.O. Home- versus office-based buprenorphine inductions for opioid-dependent patients. Journal of Substance Abuse Treatment (2009) 2009 Oct 2. [Electronic publication ahead of print] PMID: 19801178
25. Spitzer R.L., Kroenke K., and Williams J.B. Validation and utility of a self-report version of Prime-MD: The PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 282 (1999) 1737-1744 PMID: 10568646
26. Stein M.D., Cioe P., and Friedmann P.D. Buprenorphine retention in primary care. Journal of General Internal Medicine 20 (2005) 1038-1041 16307630
27. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2007 National Survey on Drug Use and Health: National Findings. (Office of Applied Studies, NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD (2008)
28. Tracy K., Baker S., LoCastro J., Mezinskis J., Simon S., and Somoza E. The substance Clinical Global Impression Scale: Measuring global functioning in substance related clinical trials. NIDA Research Monograph 180 (2000) 169
29. Walley A.Y., Alperen J.K., Cheng D.M., Botticelli M., Castro-Donlan C., Samet J.H., et al. Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers. Journal of General Internal Medicine 23 (2008) 1393-1398 PMID: 18592319
30. Wesson D.R., and Ling W. The clinical opiate withdrawal scale (COWS). Journal of Psychoactive Drugs 35 (2003) 253-259 PMID: 12924748
31. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: Reliability, validity, and sensitivity. British Journal of Psychiatry 133 (1978) 429-435 PMID: 728692